F
Fredrik Ivars
Researcher at Lund University
Publications - 52
Citations - 3393
Fredrik Ivars is an academic researcher from Lund University. The author has contributed to research in topics: T cell & Natural killer T cell. The author has an hindex of 25, co-authored 52 publications receiving 3092 citations. Previous affiliations of Fredrik Ivars include Pasteur Institute.
Papers
More filters
Journal ArticleDOI
CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells.
TL;DR: It is found that CD4+CD25+ T cells down‐regulated the expression of the co‐stimulatory molecules CD80 and CD86 on dendritic cells, suggesting that distinct mechanisms regulate theexpression of these molecules.
Journal ArticleDOI
Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis
Smriti M. Agrawal,Per Anderson,Madeleine Durbeej,Nico van Rooijen,Fredrik Ivars,Ghislain Opdenakker,Lydia Sorokin +6 more
TL;DR: It is shown here that macrophage-derived gelatinase (matrix metalloproteinase [MMP]-2 and MMP-9) activity is crucial for leukocytes penetration of the parenchymal BM, the first description of selective in situ proteolytic damage of a BBB-specific molecule at sites of leukocyte infiltration.
Journal ArticleDOI
Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression.
TL;DR: It is proposed that Treg cells down‐modulate B7‐molecules on DCs in a CTLA‐4‐dependent way, thereby enhancing suppression of T‐cell activity.
Journal ArticleDOI
Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides
Per Björk,Anders Björk,Thomas Vogl,Martin Stenström,David Liberg,Anders Olsson,Johannes Roth,Fredrik Ivars,Tomas Leanderson +8 more
TL;DR: The specific binding of quinoline-3-carboxamides to S100A9 explains the immunomodulatory activity of this class of compounds and defines S 100A9 as a novel target for treatment of human autoimmune diseases.
Journal ArticleDOI
Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain.
Chuan Wu,Fredrik Ivars,Per Anderson,Rupert Hallmann,Dietmar Vestweber,Per Nilsson,Horst Robenek,Karl Tryggvason,Jian Song,Eva Korpos,Karin Loser,Stefan Beissert,Elisabeth Georges-Labouesse,Lydia Sorokin +13 more
TL;DR: It is shown that targeting lymphocyte interactions with endothelial basement membrane laminins provides a means of inhibiting disease without compromising innate immune responses, and that T lymphocytes use mechanisms distinct from other immune cells to penetrate the endothelium basement membrane barrier.